Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem

Poor glycaemic control ups risk of stent failure in T2D patients
Poor glycaemic control appears to contribute to coronary stent failure driven by in-stent restenosis in patients with type 2 diabetes (T2D), suggests a study.
Poor glycaemic control ups risk of stent failure in T2D patients
12 Jul 2024
Real-world data support DOACs over warfarin for VTE
The direct oral anticoagulants (DOACs) apixaban and rivaroxaban trump warfarin for the treatment of venous thromboembolism (VTE) in a retrospective observational analysis comprising real-world VTE patients from Finland, Norway, and Sweden.
Real-world data support DOACs over warfarin for VTE
12 Jul 2024
DESTINY-Breast03 reports longest OS in previously treated HER2-positive mBC
Long-term follow-up of the DESTINY-Breast03 trial has reported a median overall survival (OS) of 52.6 months with trastuzumab deruxtecan (T-DXd), representing the longest reported OS in previously treated HER2-positive metastatic breast cancer (mBC) to date.
DESTINY-Breast03 reports longest OS in previously treated HER2-positive mBC
12 Jul 2024
Novel antireflux device shows potential for treatment of PPI-refractory GERD
Patients suffering from gastroesophageal reflux disease (GERD) and ineffective esophageal motility (IEM) may benefit from the novel RefluxStop device implantation, a safe and minimally invasive technology that offers potential benefits, a study has shown.
Novel antireflux device shows potential for treatment of PPI-refractory GERD
11 Jul 2024
Statin use tied to joint replacement risk
A French study presented at EULAR 2024 reveals an association between statin treatment and an increased risk of total joint replacement in individuals with knee and hip osteoarthritis (OA).




